|
|
Volumn 68, Issue 11, 2008, Pages 4031-4033
|
|
Profiling of immune response to guide cancer diagnosis, prognosis, and prediction of therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BIOLOGICAL MARKER;
RITUXIMAB;
CYTOKINE;
ADAPTIVE IMMUNITY;
B CELL LYMPHOMA;
CANCER DIAGNOSIS;
CANCER THERAPY;
CD8+ T LYMPHOCYTE;
CELL INFILTRATION;
CLINICAL EVALUATION;
COLON CARCINOMA;
CONFERENCE PAPER;
CYTOTOXIC T LYMPHOCYTE;
DISEASE COURSE;
EFFECTOR CELL;
GENETIC VARIABILITY;
HELPER CELL;
HEPATITIS C;
IMMUNE RESPONSE;
IMMUNOREGULATION;
IMMUNOTHERAPY;
INNATE IMMUNITY;
KIDNEY CARCINOMA;
MELANOMA;
MEMORY T LYMPHOCYTE;
OUTCOME ASSESSMENT;
PREDICTION;
PREDICTOR VARIABLE;
PRIORITY JOURNAL;
PROGNOSIS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
T LYMPHOCYTE;
BLOOD;
DISEASE FREE SURVIVAL;
GENETICS;
HUMAN;
IMMUNOLOGY;
NEOPLASM;
PATHOLOGY;
BIOLOGICAL MARKERS;
CYTOKINES;
DISEASE-FREE SURVIVAL;
HUMANS;
NEOPLASMS;
PROGNOSIS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
T-LYMPHOCYTES;
VARIATION (GENETICS);
|
|
EID: 49249100295
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: 10.1158/0008-5472.CAN-08-0521 Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (0)
|
